The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: A pilot study
References (33)
- et al.
Analysis of an expression profile of genes in the human adipose tissue
Gene
(1997) - et al.
Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma
Thromb Res.
(2005) - et al.
Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])
Am J Cardiol.
(1997) - et al.
Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
Am J Cardiol.
(2006) - et al.
Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia
J Am Coll Cardiol.
(2005) - et al.
Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model
J Am Coll Cardiol.
(2004) - et al.
Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome
Biomed Pharmacother
(2004) - et al.
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
Biochem Biophys Res Commun
(1999) - et al.
Adiponectin and metabolic syndrome
Arterioscler Thromb Vasc Biol.
(2004) - et al.
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)
Biochem Biophys Res Commun.
(1996)
The variation of plasma concentrations of a novel, adipocyte, derived protein, adiponectin, in patients with acute myocardial infarction
Heart
(2003)
Adiponectin is inversely related to plasminogen activator inhibitor type 1 in patients with stable exertional angina
Thromb Haemost
(2004)
Hypoadiponectinemia is associated with coronary artery spasm in men
Circ J.
(2005)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial
JAMA
(2001)
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
N Engl J Med.
(1995)
Cited by (46)
Bioconversion of mevastatin to pravastatin by various microorganisms and its applications – A review
2018, Biocatalysis and Agricultural BiotechnologyCould changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin
2015, Atherosclerosis SupplementsStatin treatment and new-onset diabetes: A review of proposed mechanisms
2014, Metabolism: Clinical and ExperimentalHead-to-head comparison of fibrates versus statins for elevation of circulating adiponectin concentrations: A systematic review and meta-analysis
2013, Metabolism: Clinical and ExperimentalImpact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: The PREMIUM Study
2012, Journal of CardiologyCitation Excerpt :In previous reports, total adiponectin levels increased after 6 months, but not 3 months of treatment [21,22]. In addition, pravastatin treatment for 6 months was shown to increase serum adiponectin concentrations in Japanese patients with CHD [34]. The period of 12 weeks might have been too short.
Copyright © 2006 Published by Elsevier Inc.